Aleksandra Inic-Kanada

Title: Aleksandra Inic-Kanada: Innovator in Ocular Therapeutics

Introduction

Aleksandra Inic-Kanada is a notable inventor based in Vienna, Austria. She has made significant contributions to the field of ocular therapeutics, particularly through her innovative vaccine formulation aimed at ocular immunization. Her work is essential for advancing treatments that can benefit both humans and animals.

Latest Patents

Inic-Kanada holds one patent titled "Vaccine formulation for ocular immunization." This invention focuses on developing subunit vaccines that effectively combat pathogens causing ocular infections in various species, including mammals and birds. The formulation includes a subunit vaccine antigen designed to provoke a protective immune response, along with at least two adjuvants, one of which is corpuscular. This innovative approach aims to induce both local and systemic immune responses, preventing the recurrence of ocular infections and mitigating the severity of related complications.

Career Highlights

Aleksandra Inic-Kanada is affiliated with the Medical University of Vienna, where she conducts her research and development work. Her expertise in ocular therapeutics has positioned her as a key figure in this specialized field.

Collaborations

In her professional journey, Inic-Kanada collaborates with Talin Barisani-Asenbauer, who is also involved in the research and development of ocular therapeutics. Their partnership enhances the potential for innovative solutions in this area.

Conclusion

Aleksandra Inic-Kanada's contributions to ocular therapeutics through her patented vaccine formulation highlight her role as an influential inventor. Her work not only advances scientific knowledge but also has the potential to improve health outcomes for both humans and animals.